| SESSION NAME |
ASAM (Pharmacists, Pyschologists, Physicians, Physicians Assistants) |
ASWB (Social Worker) |
NEMSD (Nurses) |
NAADAC (Counselor) |
| SATURDAY | ASAM | ASWB | NEMSD | NAADAC |
| The Certified Medication Assistd Treatment Advocate (CMA) Training Course (Registration Required) | 0 | 8.0 | 8.0 | 8.0 |
| MAT Waiver Training | 8.5 | 8.5 | 8.5 | 8.5 |
| Romancing the Brain/Conflict Resolution in Recovery (CRR) | 0 | 7.5 | 7.5 | 7.5 |
| Confidentiality and MAT | 3.0 | 3.0 | 3.0 | 3.0 |
| Accreditation | 4.0 | 4.0 | 4.0 | 4.0 |
| Triple E for HCV Engagement Education and Eradication | 4.0 | 4.0 | 4.0 | 4.0 |
| SUNDAY | ASAM | ASWB | NEMSD | NAADAC |
| Opioid Maintenance Pharmacotherapy: A Course for Clinicians (Registration Required) | 8.0 | 8.0 | 8.0 | 8.0 |
| Long-acting Opioid Agonist Medications: Research and Clinical Practice | 4.0 | 4.0 | 4.0 | 4.0 |
| Transforming Care Delivery: High Reliability in Medication Assisted Treatment | 3.0 | 3.0 | 3.0 | 3.0 |
| Expanding Access to MAT in Correctional Settings | 3.0 | 3.0 | 3.0 | 3.0 |
| Presentations by the World Federation for the Treatment of Opioid Dependence | 4.0 | 4.0 | 4.0 | 4.0 |
| Florida Judges and Court Staff Session (Closed Session) | 4.0 | 4.0 | 4.0 | 4.0 |
| MONDAY | ASAM | ASWB | NEMSD | NAADAC |
| Poster Sessions | 1.25 | 1.25 | 1.25 | 1.25 |
| PL1: Opening Plenary Session: State of Affairs – The Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| A1: Foundations of Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A2: The Criminal Justice System: An Effective Access Point to Treating Opioid Addiction | 1.5 | 1.5 | 1.5 | 1.5 |
| A3: Community Engagement Workshop for Opioid Treatment Programs | 1.5 | 1.5 | 1.5 | 1.5 |
| A4: Practical Methods to Increase Retention in Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A5: A Clinical Conundrum: Pain, Addiction or Both | 1.5 | 1.5 | 1.5 | 1.5 |
| #1: State Actions to Support Provider Innovation: Statutory, Regulatory and Administrative Reform | 1.5 | 1.5 | 1.5 | 1.5 |
| #2: When Disaster Strikes: Partnerships and Strategies for a Coordinated Response to Hurricane Florence | 1.5 | 1.5 | 1.5 | 1.5 |
| #3: Claims Trends and Risk Management in an Increasingly Litigious World | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: The Image of MAT and Related Stigma: Challenges and Opportunities | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Using Technology to Improve Care | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Medications for Opioid Use Disorders: Which One is Best? | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Legal Cannabis in OTPs: Implications for Programs and Treatment Plans | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Insurance Parity (MHPAEA) and Access: An Uncertain Present and Future | 0 | 1.5 | 1.5 | 1.5 |
| Poster Sessions | 1.0 | 1.0 | 1.0 | 1.0 |
| B1: Therapeutic Partnerships: The Most Important Evidence-Based Practice | 1.5 | 1.5 | 1.5 | 1.5 |
| B2: Connecting Community Outpatient Treatment Program to Corrections for Pregnant Patients | 1.5 | 1.5 | 1.5 | 1.5 |
| B3: Improving LGBT+ Care Through Inclusivity: A Community-Based Perspective | 1.5 | 1.5 | 1.5 | 1.5 |
| B4: Community Technical Assistance in Response to the Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| B5: Recovery Coaching in OTPs: Making a Difference | 1.5 | 1.5 | 1.5 | 1.5 |
| TUESDAY | ASAM | ASWB | NEMSD | NAADAC |
| PL2: Middle Plenary Session: A Continuum of Care: The Criminal Justice Role in Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| C1: Assessment and Treatment for Patients with Co-Occurring Disorders | 1.5 | 1.5 | 1.5 | 1.5 |
| C2: Implementing Medication Assisted Treatment in the Justice System | 1.5 | 1.5 | 1.5 | 1.5 |
| C3: MAT in the Middle of Nowhere: Clever Solutions to a Rural Health Crisis | 1.5 | 1.5 | 1.5 | 1.5 |
| C4: Enhancing Patient Care by Avoiding Burnout and Compassion Fatigue | 1.5 | 1.5 | 1.5 | 1.5 |
| C5: Tackling Stigma Associated with SUDs | 1.5 | 1.5 | 1.5 | 1.5 |
| D1: Group Therapy for Substance Use Disorders: Basics and Beyond | 1.5 | 1.5 | 1.5 | 1.5 |
| D2: Anywhere, Anytime: A Model for Universal Access to Opioid Medication | 1.5 | 1.5 | 1.5 | 1.5 |
| D3: Racial and Ethnic Disparities in OUD: Implications for Cultural-Competence | 1.5 | 1.5 | 1.5 | 1.5 |
| D4: Managing Co-occurring Opioid Use Disorder and Chronic Pain | 1.5 | 1.5 | 1.5 | 1.5 |
| D5: Implementing Telehealth in MAT to Better Serve Rural Areas | 1.5 | 1.5 | 1.5 | 1.5 |
| The Role of Craving and Dual Disorders in Organizing Services for Heroin Addicts | 1.5 | 1.5 | 1.5 | 1.5 |
| WEDNESDAY | ASAM | ASWB | NEMSD | NAADAC |
| E1: Strengthening Trauma Informed Practices Within OTPs | 1.5 | 1.5 | 1.5 | 1.5 |
| E2: Implementing and Sustaining Enhanced MAT in Corrections: Considerations for Diversion, Recidivism and Saving Lives | 1.5 | 1.5 | 1.5 | 1.5 |
| E3: Therapeutic use of Cannabis: Facts, Myths, & Policy Considerations | 1.5 | 1.5 | 1.5 | 1.5 |
| E4: Peer Services for Medication Assisted Treatment (The MARS Project) | 1.5 | 1.5 | 1.5 | 1.5 |
| E5: Resistance or Resilience: Mind and Body Responses | 1.5 | 1.5 | 1.5 | 1.5 |
| F1:Shattering the Stigma and Shedding the Shame | 1.5 | 1.5 | 1.5 | 1.5 |
| F2: Naloxone Distribution in the Opioid Treatment Program Setting | 1.5 | 1.5 | 1.5 | 1.5 |
| F3: Breaking All Barriers: Increasing Access to Care through the Country’s First 24/7 OTP | 1.5 | 1.5 | 1.5 | 1.5 |
| F4: Unleash The Power of Parents & Peers: Engaging & Empowering Families | 1.5 | 1.5 | 1.5 | 1.5 |
| F5: Using Technology to Empower Families and Concerned Others to Support Loved Ones with Opioid Use Disorder | 1.5 | 1.5 | 1.5 | 1.5 |
| PL3: Closing Plenary Session: Combating the Opioid Epidemic as a Nation and around the World | 1.5 | 1.5 | 1.5 | 1.5 |
As supporters of #MedicationAssistedTreatment, we understand the dangers of allowing methadone – a Schedule II narcotic – to be distributed at local pharmacies.
ACT NOW by telling Congress to protect the #OTP standard of care & our communities: https://programnotapill.com/write-congress/ #PNAP
#aatod2022 conference
AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014
Contact Us
Phone : 212-566-5555
Email : info@aatod.org
Social Sharing
